Chief Financial Officer Ben Taylor outlined the company’s integrated approach to AI-enabled drug discovery and development, ...

Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion’s Chief Medical Officer ...

A month has gone by since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have lost about 16.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $2.94, moving -6.67% from the previous trading session. This change lagged the S&P 500's daily loss of 1.67%. At the same time, ...

Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...

Ahead of her live show, the content creator behind the popular Instagram account takes us through some of her strangest ...

Roche Is Getting A Supercomputer. Why That's A Big Deal. Pharma companies are racing to acquire microchips and achieve the most powerful AI capacity in the industry. Experts say it's encouraging for ...

Sougwen Chung is presenting new works as part of Art Basel Hong Kong’s inaugural Zero 10 sector, dedicated to art of the ...

GPU behemoth Nvidia’s most important metric isn’t its data center revenue, hyperscaler capex trends, or the yield on its ...

Detailed price information for Kalvista Pharmaceuticals Inc (KALV-Q) from The Globe and Mail including charting and trades.

ARK Invest sold $84M in Meta, Nvidia, AMD, and chip stocks on March 26, 2026. See why Cathie Wood trimmed big tech and what ...

According to TipRanks.com, Stranahan is a 4-star analyst with an average return of 5.0% and a 49.9% success rate. Stranahan covers the Healthcare sector, focusing on stocks such as Day One ...